CN102657824A - Medicine used for treating fracture - Google Patents
Medicine used for treating fracture Download PDFInfo
- Publication number
- CN102657824A CN102657824A CN2012101738574A CN201210173857A CN102657824A CN 102657824 A CN102657824 A CN 102657824A CN 2012101738574 A CN2012101738574 A CN 2012101738574A CN 201210173857 A CN201210173857 A CN 201210173857A CN 102657824 A CN102657824 A CN 102657824A
- Authority
- CN
- China
- Prior art keywords
- medicine
- milligrams
- promoting
- stasis
- fracture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine used for treating fracture and belongs to the technical field of medical preparation. The invention adopts the following technical schemes: the medicine comprises 60-70mg of euonymus fortunei, 20-30mg of fortune drynaria rhizome, 30-40mg of catechu, 10-30mg of asystasia chelonoides, 10-30mg of radix curcuma and 10-20mg of painted euphorbia herb. The medicine has the effects of tonifying the kidney and strengthening the waist, relaxing muscles and activating collaterals, stopping bleeding and removing blood stasis, tonifying kidney and strengthening bones, promoting blood circulation and stopping pain, astringing dampness and regenerating tissue to heal wound, setting fracture, breaking stasis and promoting the circulation of qi, activating collaterals and relieving pain and eliminating stasis and relieving swelling.
Description
Technical field: the invention belongs to the medicinal preparation technical field, is a kind of medicine of treating fracture specifically.
Background technology: fracture is clinical wound commonly encountered diseases, frequently-occurring disease.At present; Mainly be small splints fixation behind the employing manual reduction clinically, take medicine and anti-inflammatory, repercussive and analgesic treatment or Traditional Chinese Medicine for external application blood circulation promoting and blood stasis dispelling that can not promote that like this promoting tissue regeneration and ulcer healing and sclerotin are involutory, treatment is long especially the course of treatment; Poisonous side effect of medicine is big, and therapeutic effect is not obvious.
Summary of the invention: the purpose of this invention is to provide that a kind of curative effect is obvious when carrying out fractures to patient, toxic and side effects is little, and can expelling pus and promoting granulation, the medicine of the treatment fracture of blood circulation promoting and blood stasis dispelling, detumescence, pain relieving, strengthening the tendons and bones, synthetism.
The present invention adopts following technical scheme.Form by the medicine that contains following active princlple scope for every part:
Caulis Seu Folium Euonymi Fortunei 60-70 milligram; Rhizoma Drynariae 20-30 milligram; Catechu 30-40 milligram; Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) 10-30 milligram; Rhizoma Curcumae Longae 10-30 milligram; Herba Euphorbiae Heterophyllae 10-20 milligram.
The present invention can be made up of the medicine that contains following active component for every part:
65 milligrams of Caulis Seu Folium Euonymi Fortuneis; 25 milligrams of Rhizoma Drynariae; 35 milligrams in catechu; 20 milligrams of Asystasia gangetica (L) Anders.(A. Coromandelihas Nees); 20 milligrams in Rhizoma Curcumae Longae; 15 milligrams of Herba Euphorbiae Heterophyllaes.
The present invention is made up of Caulis Seu Folium Euonymi Fortunei, Rhizoma Drynariae, catechu, Asystasia gangetica (L) Anders.(A. Coromandelihas Nees), Rhizoma Curcumae Longae, Herba Euphorbiae Heterophyllae.The Caulis Seu Folium Euonymi Fortunei nature and flavor are bitter, suffering.Has the strong waist of kidney tonifying, relaxing muscles and tendons and activating QI and blood in the collateral, the effect of hemostasis repercussive; The Rhizoma Drynariae nature and flavor are bitter, temperature.Has the kidney invigorating bone strengthening, the effect of promoting blood circulation and stopping pain; The catechu nature and flavor are bitter, and are cold.Effect with removing dampness promoting tissue regeneration and ulcer healing; The Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) nature and flavor are hot, and are flat.Has dissipating blood stasis for subsidence of swelling, the effect of synthetism hemostasis; Rhizoma Curcumae Longae has the removing blood stasis circulation of qi promoting, the effect of inducing menstruation to relieve menalgia; The Herba Euphorbiae Heterophyllae nature and flavor are bitter, and are cold, have the effect of dissipating blood stasis for subsidence of swelling.
Said components is formed the comprehensive pharmacological action of medicine; Can strengthen waist, relaxing muscles and tendons and activating QI and blood in the collateral, hemostasis repercussive, the kidney invigorating bone strengthening, promoting blood circulation and stopping pain, removing dampness promoting tissue regeneration and ulcer healing, synthetism, removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia, dissipating blood stasis for subsidence of swelling by kidney tonifying; Treatment of fractures had significant technique effect and advantage; Up to 98%, has very high promotional value through the clinical observation cure rate.
The specific embodiment: a kind of medicine of treating fracture, form by the medicine that contains following active component for every part:
65 milligrams of Caulis Seu Folium Euonymi Fortuneis; 25 milligrams of Rhizoma Drynariae; 35 milligrams in catechu; 20 milligrams of Asystasia gangetica (L) Anders.(A. Coromandelihas Nees); 20 milligrams in Rhizoma Curcumae Longae; 15 milligrams of Herba Euphorbiae Heterophyllaes.Capsule is dressed up in sterilization behind the dry porphyrize of said medicine to get final product.
Claims (1)
1. medicine of treating fracture, 65 milligrams of Caulis Seu Folium Euonymi Fortuneis; 25 milligrams of Rhizoma Drynariae; 35 milligrams in catechu; 20 milligrams of Asystasia gangetica (L) Anders.(A. Coromandelihas Nees); 20 milligrams in Rhizoma Curcumae Longae; 15 milligrams of Herba Euphorbiae Heterophyllaes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101738574A CN102657824A (en) | 2012-05-22 | 2012-05-22 | Medicine used for treating fracture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101738574A CN102657824A (en) | 2012-05-22 | 2012-05-22 | Medicine used for treating fracture |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102657824A true CN102657824A (en) | 2012-09-12 |
Family
ID=46767491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101738574A Pending CN102657824A (en) | 2012-05-22 | 2012-05-22 | Medicine used for treating fracture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102657824A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142676A (en) * | 2012-11-28 | 2013-06-12 | 杨本勤 | Bone setting blood stasis dispersing muscle tissue regeneration pill |
CN105079725A (en) * | 2015-10-08 | 2015-11-25 | 王磊 | Traditional Chinese medicine composition for treating bone fractures |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1808172A2 (en) * | 2002-03-06 | 2007-07-18 | The Medical Research and Education Trust | Botanical extract compositions and methods of use |
CN101204487A (en) * | 2007-12-20 | 2008-06-25 | 王文昇 | Chinese traditional medicine for fracture |
CN101623424A (en) * | 2008-07-08 | 2010-01-13 | 吴彦勇 | Chinese medicinal composition for treating fracture |
CN102133317A (en) * | 2011-03-15 | 2011-07-27 | 程卫东 | Medicament for treating fracture and preparation method thereof |
CN102205020A (en) * | 2011-05-18 | 2011-10-05 | 王法印 | Traditional Chinese medicine for treating traumatic injury |
CN102309644A (en) * | 2011-09-28 | 2012-01-11 | 柴艳峰 | Traditional Chinese medical composition for treating bone fracture |
-
2012
- 2012-05-22 CN CN2012101738574A patent/CN102657824A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1808172A2 (en) * | 2002-03-06 | 2007-07-18 | The Medical Research and Education Trust | Botanical extract compositions and methods of use |
CN101204487A (en) * | 2007-12-20 | 2008-06-25 | 王文昇 | Chinese traditional medicine for fracture |
CN101623424A (en) * | 2008-07-08 | 2010-01-13 | 吴彦勇 | Chinese medicinal composition for treating fracture |
CN102133317A (en) * | 2011-03-15 | 2011-07-27 | 程卫东 | Medicament for treating fracture and preparation method thereof |
CN102205020A (en) * | 2011-05-18 | 2011-10-05 | 王法印 | Traditional Chinese medicine for treating traumatic injury |
CN102309644A (en) * | 2011-09-28 | 2012-01-11 | 柴艳峰 | Traditional Chinese medical composition for treating bone fracture |
Non-Patent Citations (1)
Title |
---|
洪生虎: "中药促进骨折愈合的临床研究进展", 《河南中医》, vol. 31, no. 12, 31 December 2011 (2011-12-31), pages 1352 - 1354 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142676A (en) * | 2012-11-28 | 2013-06-12 | 杨本勤 | Bone setting blood stasis dispersing muscle tissue regeneration pill |
CN105079725A (en) * | 2015-10-08 | 2015-11-25 | 王磊 | Traditional Chinese medicine composition for treating bone fractures |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100571770C (en) | A kind of Chinese medicine cutaneous permeable agent | |
CN102961510B (en) | Vulnerary hemostatic and preparation technology thereof | |
CN104383445A (en) | Traumatic injury analgesic | |
CN102657824A (en) | Medicine used for treating fracture | |
CN104474152A (en) | Medicine good forblood stasis removal and new blood production | |
CN100588412C (en) | Chinese medicine composition for curing fracture | |
CN100381147C (en) | Rapid-acting bone wound capsules and preparation thereof | |
CN100502917C (en) | Powder medicine for clearing and activating the channels and collaterals and relieving pain | |
CN104547032A (en) | Chinese patent medicine for blood stasis stagnating syndrome | |
CN101011515A (en) | Traditional Chinese medicine composition for treating traumatic injury and bone fracture | |
CN109248288A (en) | A kind of drug and preparation method thereof for treating rheumatism | |
CN104474153A (en) | Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration | |
CN103585257A (en) | Traditional Chinese medicine powder for treating fractures | |
CN103751484A (en) | External medicinal liquor for treating fibromyalgia | |
CN1075730C (en) | Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder | |
CN101244138B (en) | Externally used traditional Chinese medicine preparation for treating frostbite | |
CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
CN106109854A (en) | A kind of pharmaceutical composition promoting skin wound healing | |
CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
CN101837083B (en) | Ointment for curing burns and scalds and preparation method thereof | |
CN103142676A (en) | Bone setting blood stasis dispersing muscle tissue regeneration pill | |
CN104666653A (en) | Traditional Chinese medicine ointment for treating arthritis of knee cap and preparation method of traditional Chinese medicine ointment | |
CN103566110A (en) | Bonesetting traditional Chinese medicine | |
CN104547075A (en) | Chinese patent medicine for removing stasis and regenerating muscle | |
CN1167437C (en) | Prescription of medicine for curing heloma and planter wart |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120912 |